Skip to main content
Fig. 1 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 1

From: The added value of positron emission tomography/computed tomography (PET/CT) in assessment of treatment response of secondary malignant osseous lesions: our experience

Fig. 1

Follow up post chemotherapy regimen for patient with cancer breast and isolated bony metastatic disease a axial CT bone window and b, c corresponding PET/CT fused image showing multiple iliac and sacral lesions, the lesion with highest SUV max value was the lytic lesion targeting the posterior asepct of the right iliac bone SUV max: 6.8 (arrow in b). d Axial CT pelvis and e corresponding PET/CT fused image 6 months following the chemotherapy; the lesion shows relative increase density in the CT image and signifnact decrease in FDG uptake (arrow); the SUV max value reaching 2 treatment responder

Back to article page